Managing One of the Largest Enterovirus Testing Populations, Children's Medical Center Dallas Among Leading Institutions to Quickly Adopt Cepheid's SUNNYVALE, Calif ...
Cepheid's performance in the first quarter was driven by robust growth in clinical product sales resulting from test utilization in the emerging HAI test market for Xpert MRSA, continued adoption of ...
SUNNYVALE, Calif. and BIRMINGHAM, Ala., June 27, 2022 /PRNewswire/ -- Cepheid and BioGX today announced a collaboration between the two companies to deliver a PCR test for Monkeypox that will run on ...
SYDNEY--(BUSINESS WIRE)--SpeeDx Pty, Ltd. today announced ResistancePlus® MG FleXible for the Cepheid GeneXpert® System, detecting the sexually transmitted infection (STI) Mycoplasma genitalium (Mgen) ...
Collaboration to leverage Oxford Nanopore's sequencing platform and Cepheid's GeneXpert system to advance the field of sequencing for infectious diseases OXFORD, United Kingdom and SUNNYVALE, Calif., ...
GeneXpert Anthrax tests combine sample preparation with real-time PCR (polymerase chain reaction) amplification and detection for fully automated DNA analysis. The system purifies, concentrates, ...
SUNNYVALE, Calif., Feb. 10, 2016 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that Warren Kocmond, formerly Executive Vice President and Chief Operating Officer, has been promoted to the ...
SpeeDx to bring first sample-to-answer Mycoplasma genitalium and macrolide resistance test to Europe SYDNEY--(BUSINESS WIRE)--SpeeDx Pty, Ltd. today announced the European launch of ResistancePlus® MG ...
SUNNYVALE, Calif., June 9, 2020 /PRNewswire/ -- Cepheid today announced the development of a next-generation test to assist global efforts in the fight against the spread of COVID-19 during the ...
SUNNYVALE, Calif., Sept. 29, 2020 /PRNewswire/ -- Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for Xpert® Xpress ...
SUNNYVALE, Calif., June 9, 2020 /PRNewswire/ -- Cepheid today announced the development of a next-generation test to assist global efforts in the fight against the spread of COVID-19 during the ...